Literature DB >> 33419463

Familial chylomicronemia syndrome: a case report.

Ammu Thampi Susheela1,2, Padmesh Vadakapet3, Lekshmi Pillai3, Susheela Thampi3.   

Abstract

BACKGROUND: Familial chylomicronemia is an extremely rare disease. Lipoprotein lipase deficiency, lipoprotein defect or lipoprotein receptor defect are the main genetic causes of familial chylomicronemia. CASE
PRESENTATION: We report a rare case of hypertriglyceridemia which was diagnosed at 24 days after birth. A newborn south east Asian baby born for G3P2A1 mother was presented with hematuria at 24 days at the hospital. The patient's family history is significant for pink blood in an elder sibling who died within a few months of birth without a proper diagnosis. Physical examination was not significant for any findings. Urinalysis revealed numerous RBC in the urine. Blood draw to perform renal function test revealed a characteristic pink blood. Baby's blood was normal and red in color at the time of birth. During the present visit, although most of the blood test were not able to be carried out by the regular laboratory instruments, the patient's lipid profile was alarmingly high with triglyceride levels over 4000 mg/dL. Due to a very high triglyceride level in a neonate and a significant familial history, a genetic cause of hypertriglyceridemia is suspected. Upon diagnosis, baby was discontinued of breast feeding completely and was given a special diet devoid of triglyceride and containing medium chain fatty acid diet and was also started with fenofibrate. After a month and a half, follow up tests were conducted which showed the triglyceride level was reduced to 1300 and a reversal of the blood color from pink to red. Since the imported diet was extremely expensive for the family, the patient was put on skimmed milk with medium-chain triglyceride (MCT) oil. With 6 weeks of treatment, baby's condition has improved and is thriving well.
CONCLUSIONS: Our case reports an extremely rare and fatal condition and illustrated the significance of timely diagnosis and intervention for saving the life of the baby.

Entities:  

Keywords:  Blood; Chylomicronemia; Genetic disease; Hematology; Lipoprotein

Mesh:

Substances:

Year:  2021        PMID: 33419463      PMCID: PMC7791813          DOI: 10.1186/s13256-020-02609-0

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  14 in total

1.  Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.

Authors:  Lauren Williams; Katherine S Rhodes; Wahida Karmally; Lori A Welstead; Lori Alexander; Lindsey Sutton
Journal:  J Clin Lipidol       Date:  2018-04-27       Impact factor: 4.766

2.  Strawberry Pink Blood.

Authors:  Jayashree D Kulkarni; Puneeta Bhatia; Sanjay A Pai
Journal:  Indian J Hematol Blood Transfus       Date:  2016-06-17       Impact factor: 0.900

3.  An interesting case of hypertriglyceridaemic pancreatitis.

Authors:  Anupama K Pujar; Anil Kumar V R; Sridhar M; Kulkarni S V
Journal:  J Clin Diagn Res       Date:  2013-04-29

4.  Diagnostic algorithm for familial chylomicronemia syndrome.

Authors:  Erik Stroes; Philippe Moulin; Klaus G Parhofer; Vinciane Rebours; J-Matthias Löhr; Maurizio Averna
Journal:  Atheroscler Suppl       Date:  2016-12-18       Impact factor: 3.235

5.  Targeting APOC3 in the familial chylomicronemia syndrome.

Authors:  Daniel Gaudet; Diane Brisson; Karine Tremblay; Veronica J Alexander; Walter Singleton; Steven G Hughes; Richard S Geary; Brenda F Baker; Mark J Graham; Rosanne M Crooke; Joseph L Witztum
Journal:  N Engl J Med       Date:  2014-12-04       Impact factor: 91.245

6.  Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis.

Authors:  Yu-Ting Chang; Ming-Chu Chang; Ta-Chen Su; Po-Chin Liang; Yi-Ning Su; Chun-Hung Kuo; Shu-Chen Wei; Jau-Min Wong
Journal:  Clin Chem       Date:  2007-11-02       Impact factor: 8.327

7.  An infant with milky blood : an unusual but treatable case of familial hyperlipidemia.

Authors:  Om Shankar Chaurasiya; Lalit Kumar; Rohit Shamsher Sethi
Journal:  Indian J Clin Biochem       Date:  2012-12-11

8.  Double blind trial of bezafibrate in familial hypercholesterolaemia.

Authors:  K A Wheeler; R J West; J K Lloyd; J Barley
Journal:  Arch Dis Child       Date:  1985-01       Impact factor: 3.791

Review 9.  Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.

Authors:  James M Falko
Journal:  Endocr Pract       Date:  2018-08       Impact factor: 3.443

10.  Two siblings with familial chylomicronemia syndrome: disease course and effectiveness of early treatment.

Authors:  Hanan Al Azkawi; Ibrahim Alalwan
Journal:  Case Rep Med       Date:  2010-12-27
View more
  1 in total

1.  Low circulating PCSK9 levels in LPL homozygous children with chylomicronemia syndrome in a syrian refugee family in Lebanon.

Authors:  Carine Ayoub; Yara Azar; Dina Maddah; Youmna Ghaleb; Sandy Elbitar; Yara Abou-Khalil; Selim Jambart; Mathilde Varret; Catherine Boileau; Petra El Khoury; Marianne Abifadel
Journal:  Front Genet       Date:  2022-08-19       Impact factor: 4.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.